Trial intelligence / Profile preview

TheraCal PT for Pulp Therapy in Primary Molars

NCT04167943Phase 3Completed

Sponsor
Ain Shams University
Start
Nov 2019
Primary completion
Aug 2021
Modality
Implantable Devices
Countries
1
01

Overview

A Phase 3 trial of TheraCal in reversible pulpitis, sponsored by Ain Shams University. Started Nov 2019; status: completed.

02

Drugs

TheraCal
03

Conditions

reversible pulpitis

Beyond the preview

Go deeper on NCT04167943.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04167943.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call